SEC Comment Letter 0000000000-23-002466 to Q32 Bio Inc. (QTTB)
Q32 Bio Inc.
Date: March 14, 2023 · CIK: 0001661998 · Accession: 0000000000-23-002466
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270414
Letter
United States securities and exchange commission logo March 14, 2023 Paul Alloway General Counsel Homology Medicines, Inc. One Patriots Park Bedford, Massachusetts 01730 Re:Homology Medicines, Inc. Registration Statement on Form S-3 Filed March 9, 2023 File No. 333-270414 Dear Paul Alloway: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Arzhang Navai at 202-551-4676 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Wesley Holmes
Show Raw Text
United States securities and exchange commission logo
March 14, 2023
Paul Alloway
General Counsel
Homology Medicines, Inc.
One Patriots Park
Bedford, Massachusetts 01730
Re:Homology Medicines, Inc.
Registration Statement on Form S-3
Filed March 9, 2023
File No. 333-270414
Dear Paul Alloway:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Arzhang Navai at 202-551-4676 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Wesley Holmes